Table 3.

Most common adverse events related to the combination treatment

Cohort group
1 (n = 3)2 (n = 4)3 (n = 4)4 (n = 3)5 (n = 5)6 (n = 4)Total (n = 23; %)Grade >2 (n = 23; %)
Pyrexia11112410 (43.5)0
Lymphopenia3210006 (26.1)1 (4.3)
Influenza-like symptoms1200014 (17.4)0
Vomiting0100214 (17.4)0
Erythema0001124 (17.4)0
Diarrhea0101103 (13.0)0
Fatigue0110013 (13.0)0
Nausea0100113 (13.0)0
Neutropenia1100103 (13.0)0
Infection0110103 (13.0)2 (8.7)
Headache0010102 (8.7)0
Injection site pain0100102 (8.7)0
Rash0110002 (8.7)0